デジタル呼吸器市場- 世界の産業規模、シェア、動向、機会、予測、製品別、適応症別、流通チャネル別、地域別、競合別、2020-2030年

デジタル呼吸器の世界市場規模は2024年に432億1,000万米ドルで、予測期間には775億4,000万米ドルに達すると予測され、2030年までのCAGRは10.21%です。

ヘルスケア業界はデジタル変革期を迎えており、この変革は呼吸ケア分野にも及んでいます。デジタル呼吸器は、世界中で呼吸器疾患の管理、診断、治療方法に革命をもたらしています。これらの革新的なデバイスは、リアルタイムのモニタリング、個別化された治療計画、患者の転帰の改善を提供します。慢性閉塞性肺疾患（COPD）、喘息、睡眠時無呼吸症候群などの呼吸器疾患は、世界の健康問題です。そのため、これらの疾患をより効果的に管理・治療できる高度な呼吸ケアソリューションが急務となっています。

デジタル呼吸器は、ヘルスケア業界におけるゲームチェンジャーとして登場しました。最先端技術と呼吸ケアを融合させたこのデバイスは、多くのメリットをもたらします。デジタル呼吸器は、患者の肺機能と呼吸パターンのリアルタイムデータを提供します。この継続的なモニタリングにより、ヘルスケアプロバイダーは情報に基づいた判断を下し、必要に応じて治療計画を調整することができます。データ分析と機械学習アルゴリズムの助けを借りて、これらのデバイスは、各患者固有のニーズに合わせて治療計画を調整することができます。このパーソナライズされたアプローチは、治療効果と患者の満足度を高める。患者は自宅でデジタル呼吸器を使用することができ、頻繁に診療所を訪れる必要性を減らすことができます。ヘルスケア専門家は遠隔で患者の経過をモニターすることができ、悪化した場合には早期に介入することができます。多くのデジタル呼吸器には、患者の治療計画遵守を促す機能が搭載されています。これには、リマインダー、ゲーミフィケーション要素、教育リソースなどが含まれます。

市場促進要因

呼吸器疾患の増加がデジタル呼吸器の世界市場を牽引

主な市場課題

データセキュリティとプライバシーに関する懸念

主な市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のデジタル呼吸器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（スマート吸入器とネブライザー、センサーとアプリ、その他）
  • 適応症別（喘息、COPD、その他）
  • 流通チャネル別（病院薬局、小売薬局、オンライン薬局）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のデジタル呼吸器市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のデジタル呼吸器市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のデジタル呼吸器市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のデジタル呼吸器市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのデジタル呼吸器市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のデジタル呼吸器市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• COHERO Health Inc.
• Cognita Labs llc
• Adherium Limited
• Amiko Digital Health Limited
• Teva Pharmaceuticals Industries Ltd.
• Propeller Health
• Novartis AG
• Pneuma Respiratory Inc.
• 3M Health Care Limited
• AireHealth, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Digital Respiratory Devices Market was valued at USD 43.21 Billion in 2024 and is expected to reach USD 77.54 Billion in the forecast period with a CAGR of 10.21% through 2030. The healthcare industry is undergoing a digital transformation, and this transformation extends to the field of respiratory care. Digital respiratory devices are revolutionizing the way respiratory conditions are managed, diagnosed, and treated worldwide. These innovative devices offer real-time monitoring, personalized treatment plans, and improved patient outcomes. Respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, are a global health concern. As a result, there is an urgent need for advanced respiratory care solutions that can help manage and treat these conditions more effectively.

Digital respiratory devices have emerged as a game changer in the healthcare industry. These devices combine cutting-edge technology with respiratory care, offering numerous benefits. Digital respiratory devices provide real-time data on a patient's lung function and breathing patterns. This continuous monitoring allows healthcare providers to make informed decisions and adjust treatment plans as needed. With the help of data analytics and machine learning algorithms, these devices can tailor treatment plans to each patient's unique needs. This personalized approach enhances treatment effectiveness and patient satisfaction. Patients can use digital respiratory devices at home, reducing the need for frequent clinic visits. Healthcare professionals can remotely monitor patients' progress, ensuring early intervention in case of deterioration. Many digital respiratory devices come with features that encourage patient adherence to treatment plans. These may include reminders, gamification elements, and educational resources.

Key Market Drivers

Rising Respiratory Disorders is Driving the Global Digital Respiratory Devices Market

Respiratory disorders have been on the rise worldwide, affecting millions of people and posing a significant healthcare challenge. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea have become increasingly prevalent due to factors like air pollution, smoking, and lifestyle changes. In response to this growing health concern, the global digital respiratory devices market has emerged as a crucial player in managing and monitoring these conditions effectively.

Respiratory disorders encompass a wide range of conditions that affect the lungs and airways, making it difficult for individuals to breathe properly. These disorders include asthma, COPD, pneumonia, bronchitis, and sleep apnea, among others. According to the World Health Organization (WHO), respiratory diseases are the leading cause of death worldwide, accounting for 10% of all deaths. This alarming statistic highlights the urgent need for better management and monitoring of respiratory health.

Several factors contribute to the rising prevalence of respiratory disorders. Poor air quality caused by industrial emissions, vehicular pollution, and other environmental factors can trigger and exacerbate respiratory conditions. Tobacco use remains a significant risk factor for respiratory disorders, including lung cancer, COPD, and emphysema. As more people move to cities, exposure to indoor and outdoor air pollutants increases, potentially leading to respiratory health problems. Sedentary lifestyles and unhealthy dietary habits have contributed to the rise of obesity, which is linked to respiratory conditions such as sleep apnea.

Digital respiratory devices have emerged as a crucial tool in the management and monitoring of respiratory conditions. These devices leverage cutting-edge technology to provide patients and healthcare professionals with real-time data and insights, enabling better disease management and improved quality of life. Digital respiratory devices, such as smart inhalers and continuous positive airway pressure (CPAP) machines for sleep apnea, collect and transmit data to healthcare providers. This data helps healthcare professionals monitor patients' progress and make necessary adjustments to their treatment plans. Smart inhalers are equipped with sensors that track inhaler usage. They remind patients to take their medication and provide feedback on technique, improving adherence to treatment regimens. Patients can now be monitored remotely, reducing the need for frequent clinic visits. This is especially beneficial during pandemics and for patients in remote areas. Digital respiratory devices allow for more personalized treatment plans. Healthcare providers can tailor interventions based on an individual's specific needs and responses to therapy.

Recent data from the World Health Organization (WHO) underscores the severity of respiratory diseases globally. In 2021, chronic obstructive pulmonary disease (COPD) was the fourth leading cause of death worldwide, resulting in approximately 3.5 million deaths, which accounts for about 5% of all global deaths. Additionally, air pollution remains a critical factor, with WHO reporting that almost the entire global population (99%) breathes air that exceeds WHO air quality limits, leading to significant health risks. These statistics highlight the pressing need for effective management and monitoring solutions, such as digital respiratory devices, to combat the escalating burden of respiratory disorders.

Key Market Challenges

Data Security and Privacy Concerns

Data security and privacy concerns present a significant challenge for the global digital respiratory devices market as these devices collect, store, and transmit sensitive patient health information. The integration of digital technologies, such as smart inhalers, connected nebulizers, and remote monitoring systems, relies on cloud-based platforms and mobile applications to facilitate real-time tracking and personalized treatment plans. Patients' medical histories, treatment adherence patterns, and respiratory health data are transmitted to healthcare providers, increasing the risk of cyber threats and data breaches. Unauthorized access to such data can compromise patient confidentiality, leading to potential misuse of personal health information by cybercriminals, insurance companies, or unauthorized third parties.

Regulatory frameworks, including the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe, impose strict guidelines on healthcare data security. Compliance with these regulations requires significant investments in encryption technologies, secure cloud storage solutions, and cybersecurity protocols. Many digital respiratory device manufacturers and healthcare providers face challenges in meeting these stringent standards while ensuring seamless data access for patients and clinicians. Any failure to comply with these regulations can result in legal penalties, reputational damage, and loss of consumer trust.

Key Market Trends

Technological Advancements

The healthcare industry has witnessed a remarkable transformation in recent years, primarily due to advancements in technology. One such area where technology has made substantial strides is in respiratory care. Digital respiratory devices have emerged as game-changers in the field, significantly improving the management of respiratory conditions. As a result, the global digital respiratory devices market is experiencing rapid growth, driven by innovative technologies that enhance patient care and revolutionize the way respiratory diseases are managed.

Smart inhalers have gained prominence as a breakthrough technology for managing conditions like asthma and COPD. These inhalers are equipped with sensors that monitor medication usage and inhalation technique. Patients can receive real-time feedback and reminders through smartphone apps, ensuring they adhere to their treatment plans. Internet of Things (IoT) technology has enabled the development of remote monitoring devices. These devices can track a patient's vital signs, oxygen levels, and lung function from the comfort of their homes. Healthcare providers can remotely assess data, make necessary adjustments to treatment plans, and intervene promptly when needed, reducing hospital admissions and emergency room visits. The integration of telemedicine and telehealth platforms with digital respiratory devices has enabled virtual consultations and remote disease management. Patients can consult with healthcare professionals, receive prescriptions, and access educational resources without leaving their homes. AI-powered algorithms are being utilized to analyze vast datasets generated by digital respiratory devices. This technology can predict disease exacerbations, identify trends, and provide personalized treatment recommendations based on individual patient data. Interoperability between different digital respiratory devices and electronic health records (EHRs) streamlines the sharing of patient information among healthcare providers. This connectivity enhances care coordination and ensures a holistic approach to managing respiratory conditions.

Key Market Players

• COHERO Health Inc.
• Cognita Labs llc
• Adherium Limited
• Amiko Digital Health Limited
• Teva Pharmaceuticals Industries Ltd.
• Propeller Health
• Novartis AG
• Pneuma Respiratory Inc.
• 3M Health Care Limited
• AireHealth, Inc.

Report Scope:

In this report, the Global Digital Respiratory Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Respiratory Devices Market, By Product:

• Smart Inhalers & Nebulizers
• Sensors & Apps
• Others

Digital Respiratory Devices Market, By Indication:

• Asthma
• COPD
• Others

Digital Respiratory Devices Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Digital Respiratory Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Respiratory Devices Market.

Available Customizations:

Global Digital Respiratory Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Respiratory Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Smart Inhalers & Nebulizers, Sensors & Apps, Others)
  • 5.2.2. By Indication (Asthma, COPD, Others)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Digital Respiratory Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital Respiratory Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Digital Respiratory Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Digital Respiratory Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Distribution Channel

7. Europe Digital Respiratory Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Digital Respiratory Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Digital Respiratory Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Italy Digital Respiratory Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. France Digital Respiratory Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Digital Respiratory Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Digital Respiratory Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Digital Respiratory Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Digital Respiratory Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Digital Respiratory Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Digital Respiratory Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Digital Respiratory Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Distribution Channel

9. South America Digital Respiratory Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Digital Respiratory Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Digital Respiratory Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Digital Respiratory Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Digital Respiratory Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Digital Respiratory Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Digital Respiratory Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Digital Respiratory Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Digital Respiratory Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. COHERO Health Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cognita Labs llc
• 15.3. Adherium Limited
• 15.4. Amiko Digital Health Limited
• 15.5. Teva Pharmaceuticals Industries Ltd.
• 15.6. Propeller Health
• 15.7. Novartis AG
• 15.8. Pneuma Respiratory Inc.
• 15.9. 3M Health Care Limited
• 15.10. AireHealth, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer